These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37594060)

  • 1. [Risk factors for cancer-related cognitive impairment in breast and colorectal cancer patients who undergo chemotherapy].
    Iranzo P; Callejo A; Arbej J; Menao S; Isla D; Andrés R
    An Sist Sanit Navar; 2023 Aug; 46(2):. PubMed ID: 37594060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of TNF-α (rs1800629) and IL-6 (rs1800795) Polymorphisms on Cognitive Impairment in Asian Breast Cancer Patients.
    Chae JW; Ng T; Yeo HL; Shwe M; Gan YX; Ho HK; Chan A
    PLoS One; 2016; 11(10):e0164204. PubMed ID: 27701469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immediate-term cognitive impairment following intravenous (IV) chemotherapy: a prospective pre-post design study.
    Khan OF; Cusano E; Raissouni S; Pabia M; Haeseker J; Bosma N; Ko JJ; Li H; Kumar A; Vickers MM; Tang PA
    BMC Cancer; 2019 Feb; 19(1):150. PubMed ID: 30764801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between cognitive impairment and guideline adherence for application of chemotherapy in older patients with breast cancer: Results from the prospective multicenter BRENDA II study.
    Leinert E; Schwentner L; Blettner M; Wöckel A; Felberbaum R; Flock F; Kühn T; Denkinger MD; Janni W; Kreienberg R; Singer S;
    Breast J; 2019 May; 25(3):386-392. PubMed ID: 30945393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy was not associated with cognitive decline in older adults with breast and colorectal cancer: findings from a prospective cohort study.
    Shaffer VA; Merkle EC; Fagerlin A; Griggs JJ; Langa KM; Iwashyna TJ
    Med Care; 2012 Oct; 50(10):849-55. PubMed ID: 22683591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.
    Ganz PA; Kwan L; Castellon SA; Oppenheim A; Bower JE; Silverman DH; Cole SW; Irwin MR; Ancoli-Israel S; Belin TR
    J Natl Cancer Inst; 2013 Jun; 105(11):791-801. PubMed ID: 23606729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.
    Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA
    Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy in early breast cancer.
    Ejlertsen B
    Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological Effects of Chemotherapy: Systematic Review of Longitudinal Studies on Objective Cognitive Impairment in Breast Cancer Patients.
    Kim HJ; Kim JEE; Jung SO; Lee D; Abraham I
    Cancer Nurs; 2023 May-Jun 01; 46(3):E159-E168. PubMed ID: 35324504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy-associated cognitive impairments in Korean cancer patients: Risk factors and functional outcome.
    Kim HJ; Barsevick AM; Chan A; Chae JW
    Psychooncology; 2018 Aug; 27(8):1995-2001. PubMed ID: 29744963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Adjuvant Chemotherapy on Cognitive Function of Patients With Early-stage Colorectal Cancer.
    Sales MVC; Suemoto CK; Apolinario D; Serrao V; Andrade CS; Conceição DM; Amaro E; de Melo BAR; Riechelmann RP
    Clin Colorectal Cancer; 2019 Mar; 18(1):19-27. PubMed ID: 30297263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive effects of adjuvant endocrine therapy in older women treated for early-stage breast cancer: a 1-year longitudinal study.
    Underwood EA; Jerzak KJ; Lebovic G; Rochon PA; Elser C; Pritchard KI; Tierney MC
    Support Care Cancer; 2019 Aug; 27(8):3035-3043. PubMed ID: 30610433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal investigation of cognitive deficits in breast cancer patients and their gray matter correlates: impact of education level.
    Perrier J; Viard A; Levy C; Morel N; Allouache D; Noal S; Joly F; Eustache F; Giffard B
    Brain Imaging Behav; 2020 Feb; 14(1):226-241. PubMed ID: 30406352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study.
    Cheung YT; Ng T; Shwe M; Ho HK; Foo KM; Cham MT; Lee JA; Fan G; Tan YP; Yong WS; Madhukumar P; Loo SK; Ang SF; Wong M; Chay WY; Ooi WS; Dent RA; Yap YS; Ng R; Chan A
    Ann Oncol; 2015 Jul; 26(7):1446-51. PubMed ID: 25922060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence and characteristics of chemotherapy-related cognitive impairment in patients with breast cancer].
    Park JH; Bae SH; Jung YS; Jung YM
    J Korean Acad Nurs; 2015 Feb; 45(1):118-28. PubMed ID: 25743740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Acupuncture Therapy for Chemotherapy-Related Cognitive Impairment in Breast Cancer Patients.
    Tong T; Pei C; Chen J; Lv Q; Zhang F; Cheng Z
    Med Sci Monit; 2018 May; 24():2919-2927. PubMed ID: 29735975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verbal memory in breast cancer patients treated with chemotherapy with doxorubicin and cyclophosphamide.
    Andryszak P; Wiłkość M; Żurawski B; Izdebski P
    Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 28850754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer plus adjuvant chemotherapy- related cognitive impairment: a case study.
    Fischer B
    Neurocase; 2019; 25(3-4):138-144. PubMed ID: 31237172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive Changes After Adjuvant Treatment in Older Adults with Early-Stage Breast Cancer.
    Lange M; Heutte N; Noal S; Rigal O; Kurtz JE; Lévy C; Allouache D; Rieux C; Lefel J; Clarisse B; Leconte A; Veyret C; Barthélémy P; Longato N; Tron L; Castel H; Eustache F; Giffard B; Joly F
    Oncologist; 2019 Jan; 24(1):62-68. PubMed ID: 29934409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prechemotherapy Levels of Plasma Dehydroepiandrosterone and Its Sulfated Form as Predictors of Cancer-Related Cognitive Impairment in Patients with Breast Cancer Receiving Chemotherapy.
    Toh YL; Shariq Mujtaba J; Bansal S; Yeo A; Shwe M; Lau AJ; Chan A
    Pharmacotherapy; 2019 May; 39(5):553-563. PubMed ID: 30892712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.